PMID- 23872360 OWN - NLM STAT- MEDLINE DCOM- 20131213 LR - 20220317 IS - 1096-0007 (Electronic) IS - 0014-4835 (Linking) VI - 115 DP - 2013 Oct TI - Plasma rich in growth factors (PRGF-Endoret) stimulates corneal wound healing and reduces haze formation after PRK surgery. PG - 153-61 LID - S0014-4835(13)00197-8 [pii] LID - 10.1016/j.exer.2013.07.007 [doi] AB - This study evaluated the efficacy of Plasma rich in growth factors (PRGF-Endoret) on the corneal wound healing process after Photorefractive keratectomy (PRK). To address this, blood from three healthy donors was collected, centrifuged and, the whole plasma column (WP) and the plasma fraction with the highest platelet concentration (F3) were collected. The effects of F3 and WP on the proliferation and migration of human corneal epithelial cells (HCE) were analyzed. PRK was performed on C57BL/6 mice. Animals were divided in three treatment groups: Control, F3, and WP. Corneal wound healing and haze formation were evaluated macroscopically. Eyes were collected at 1, 2, 3, and 7 days after surgery, and were processed for histological studies. Immunofluorescence was used to assess cellular proliferation, apoptosis and myofibroblast transformation in the mouse cornea. Results showed a significant increased on proliferation and wound healing after F3 and WP treatment when compared with control group. In vivo studies showed significant reduction on haze formation in mice treated with both PRGF-Endoret formulations (F3 and WP). Histological studies showed an increase of epithelial cell proliferation in corneas of control group, promoting an epithelial hyperplasia. The number of SMA-positive cells (corresponding to myofibroblast differentiation) was significantly lower in the PRGF-Endoret group than in the control group, correlating with the higher transparence results observed macroscopically in both PRGF-Endoret groups. According to this, it can be concluded that PRGF-Endoret accelerates corneal tissue regeneration after PRK, reducing haze formation. CI - Copyright (c) 2013 Elsevier Ltd. All rights reserved. FAU - Anitua, E AU - Anitua E AD - Biotechnology Institute (BTI), Vitoria, Spain. Electronic address: eduardoanitua@eduardoanitua.com. FAU - Muruzabal, F AU - Muruzabal F FAU - Alcalde, I AU - Alcalde I FAU - Merayo-Lloves, J AU - Merayo-Lloves J FAU - Orive, G AU - Orive G LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130718 PL - England TA - Exp Eye Res JT - Experimental eye research JID - 0370707 RN - 0 (Intercellular Signaling Peptides and Proteins) RN - 0 (Ophthalmic Solutions) SB - IM MH - Animals MH - Cell Proliferation MH - Cells, Cultured MH - Corneal Injuries MH - Corneal Opacity/etiology/*prevention & control MH - Disease Models, Animal MH - Enzyme-Linked Immunosorbent Assay MH - Epithelium, Corneal/cytology/metabolism MH - Fluorescent Antibody Technique, Indirect MH - Humans MH - In Situ Nick-End Labeling MH - Intercellular Signaling Peptides and Proteins/*physiology MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Ophthalmic Solutions MH - *Photorefractive Keratectomy MH - Platelet-Rich Plasma/*physiology MH - Postoperative Complications/*prevention & control MH - Wound Healing/*physiology OTO - NOTNLM OT - Corneal epithelial cells OT - ECM OT - EGF OT - ELISA OT - Enzyme-linked immunosorbent assay OT - Epithelial growth factor OT - Extracellular matrix OT - FBS OT - FGF OT - Fetal bovine serum OT - Fibroblast growth factor OT - HCE OT - NGF OT - Nerve growth factor OT - PBS OT - PDGF OT - PRGF-Endoret OT - PRK OT - PRP OT - Phosphate buffered saline OT - Photorefractive keratectomy OT - Plasma Rich in Growth Factors OT - Platelet-derived growth factor OT - SMA OT - Smooth muscle actin OT - TGF OT - TUNEL assay OT - Terminal deoxyribonucleotidyl transferase-mediated dUTP-fluorescein Nick-End labeling assay OT - Transforming growth factor-beta OT - cornea OT - myofibroblast OT - plasma rich in growth factors OT - platelet-rich plasma OT - wound healing EDAT- 2013/07/23 06:00 MHDA- 2013/12/18 06:00 CRDT- 2013/07/23 06:00 PHST- 2013/01/28 00:00 [received] PHST- 2013/06/19 00:00 [revised] PHST- 2013/07/09 00:00 [accepted] PHST- 2013/07/23 06:00 [entrez] PHST- 2013/07/23 06:00 [pubmed] PHST- 2013/12/18 06:00 [medline] AID - S0014-4835(13)00197-8 [pii] AID - 10.1016/j.exer.2013.07.007 [doi] PST - ppublish SO - Exp Eye Res. 2013 Oct;115:153-61. doi: 10.1016/j.exer.2013.07.007. Epub 2013 Jul 18.